Emergent Technologies and Caisson Biotech are teaming up in an effort to improve drug safety and efficacy using the latter firm’s HEPtune™ drug delivery platform. With clinical support from Texas’ ...
Caisson claims heparosan has numerous advantages compared with PEGylation. Novo Nordisk negotiated a potentially $100 million deal with Caisson Biotech to secure exclusive rights to use the latter’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback